Bath & Body Works price target lowered to $30 from $35 at Barclays

Barclays analyst Adrienne Yih lowered the firm’s price target on Bath & Body Works to $30 from $35 and keeps an Equal Weight rating on the shares. The company’s Q1 results were in-line with the preliminary results for sales and earnings, the analyst tells investors in a research note. Bath & Body noted that if tariff rates remain unchanged, it would expect its fiscal 2025 results in the lower half of the guidance range, adds Barclays.